An approach to the development of novel antihypertensive drugs: Potential role of sodium pump inhibitors

Trends in Pharmacological Sciences

Volumn 19, Issue 6, 1998, Pages 201-204

  Goto, Atsuo ^a   Yamada, Kaoru ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b Sanraku Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ANTIHYPERTENSIVE AGENT; DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT; OUABAIN; PROSCILLARIDIN; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; STROKE;

EID: 0032102043     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(98)01216-4     Document Type: Article

References (38)

1. Doris P. A. Miner. Electrolyte Metab. 22:1996;303-310.
2. Hamlyn J. M., Hamilton B. P., Manunta P. J. Hypertens. 14:1996;151-167.
3. Quadri L. et al. J. Med. Chem. 140:1997;1561-1564.
4. Kannel W. B. J. Am. Med. Assoc. 275:1996;1571-1576.
5. Collins R. et al. Lancet. 335:1990;827-838.
6. Haheim L. L., Holme I., Hjermann I., Leren P. J. Hypertens. 13:1995;909-913.
7. Zhao N. et al. Biochemistry. 34:1995;9893-9896.
8. Tymiak A. A. et al. Proc. Natl. Acad. Sci. U. S. A. 90:1993;8189-8193.
9. Balzan S., Montali U., Di Bartolo V., Ghione S. Life Sci. 60:1997;893-898.
10. Worgall S. et al. J. Hypertens. 14:1996;623-628.
11. Nakanishi K. et al. Am. J. Hypertens. 10:1997;217A.
12. Qazzaz H. M. A., Goudy S. L., Valdes R. J. Biol. Chem. 271:1996;8731-8737.
13. Samuelov S., Lichtstein D. Pflügers Arch. Eur. J. Physiol. 433:1997;435-441.
14. Wright D. A. et al. Lancet. 350:1997;409.
15. Bagrov A. Y., Fedorova O. V., Dmitrieva R. I., French A. W., Anderson D. E. Cardiovasc. Res. 31:1996;296-305.
16. Sich B., Kirch U., Tepel M., Zidek W., Schoner W. Hypertension. 27:1996;1073-1078.
17. Tao Q-F., Hollenberg N. K., Price A. P., Graves S. W. Hypertension. 29:1996;815-821.
18. Krep H. H. et al. Am. J. Hypertens. 8:1995;921-927.
19. Laredo J., Shah J. R., Lu Z-R., Hamilton B. P., Hamlyn J. M. Hypertension. 29:1997;401-407.
20. Perrin A., Brasmes B., Chambaz E. M., Defaye G. Mol. Cell. Endocrinol. 126:1997;7-15.
21. Lichtstein D. et al. Am. J. Hyperten. s. 10:1997;273A.
22. Qazzaz H. M. A., Valdes R. Jr Arch. Biochem. Biophys. 328:1996;193-200.
23. Lifton R. P. Science. 272:1996;676-680.
24. Guide E. et al. J. Am. Soc. Nephrol. 7:1996;1131-1138.
25. Tripodi G. et al. J. Clin. Invest. 97:1996;2815-2822.
26. Cowley A. W. Physiol. Rev. 72:1992;231-300.
27. Zhu Z., Tepel M., Neusser M., Zidek W. Clin. Sci. 90:1996;9-12.
28. Gomez-Sanchez E. P., Gomez-Sanchez C. E., Fort C. Am. J. Hypertens. 7:1994;591-596.
29. Rossi G. et al. J. Hypertens. 13:1995;1181-1192.
30. Goto A. et al. Hypertension. 28:1996;421-425.
31. Cester N. et al. Mol. Cell. Biochem. 170:1997;125-129.
32. Huang B. S., Leenen F. H. H. Circ. Res. 74:1994;586-595.
33. Adair C. D. et al. Am. J. Nephrol. 16:1996;529-531.
34. Ferrandi M. et al. Hypertension. 30:1997;886-896.
35. Cusi D. et al. Lancet. 349:1997;1353-1357.
36. Blaustein M. P. Kidney Int. 1996;49.
37. de Wardener H. E. J. Hypertens. 14 (Suppl. 5):1996;S9-S18.
38. Goto A., Yamada K. Curr. Opin. Nephrol. Hypertens. 7:1998;189-196.